InvestorsHub Logo

MWM

Followers 1062
Posts 141568
Boards Moderated 14
Alias Born 03/31/2006

MWM

Re: None

Thursday, 09/24/2020 4:32:02 PM

Thursday, September 24, 2020 4:32:02 PM

Post# of 634
Exact Sciences Reportedly Unveils Liquid Biopsy With Multiple Cancer Detection

9/24/20, 2:50 PM
02:50 PM EDT, 09/24/2020 (MT Newswires) -- Exact Sciences (EXAS) CEO Kevin Conroy reportedly unveiled data at a summit from a liquid biopsy that detected multiple cancers from a blood sample, furthering its aim to be a dominant player in the detection market over the next five years, Bloomberg reported.

Data spanning six cancer types included lung and ovarian, and demonstrated an overall sensitivity of 86% and specificity of 95%, the news report said. While the test could detect early stage cancers, the samples were biased toward later and more developed diseases, it added.

While the findings are "still very early" and Exact Sciences has a long path to bringing the test to market, Cowen analyst Doug Schenkel was said to have been excited by the development, according to the report.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EXAS News